Researchers at Dana-Farber Cancer Institute are looking to expand treatment options for bladder cancer patients beyond surgery and chemotherapy. In what’s known as the BLASST trial, they’re adding in immunotherapy before any surgery takes place in muscle-invasive bladder cancer.
Негізгі бет Ғылым және технология Immunotherapy and Bladder Cancer
Пікірлер: 2